Treatment of Japanese restless legs syndrome patients with cabergoline: An open clinical preliminary trial

Internal Medicine

Volumn 45, Issue 7, 2006, Pages 453-455

  Aizawa, Hitoshi ^a   Aburakawa, Yoko ^a   Suzuki, Yasuhiro ^a   Enomoto, Hiroyuki ^b   Makita, Yoshihiro ^a   Kikuchi, Kenjiro ^a   Kimura, Takashi ^b   Yahara, Osamu ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Department of Neurology   (Japan)

Author keywords

Cabergoline; Clinical trial; Dopamine agonist; Levodopa; Parkinson disease; Restless legs syndrome

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMORBIDITY; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GAIT DISORDER; HUMAN; JAPAN; MALE; PARKINSON DISEASE; PARKINSONISM; QUESTIONNAIRE; RANK SUM TEST; RATING SCALE; RESTLESS LEGS SYNDROME; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR;

AGED; AGED, 80 AND OVER; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 33646433956     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1555     Document Type: Article

References (26)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101-119, 2003.
2. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19: 205-213, 1996.
3. Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24: 455-458, 1988.
4. Winkelmann J, Wetter TC, Stiasny K, Oertel WH, Trenkwalder C. Treatment of restless legs syndrome with pergolide-an open clinical trial. Mov Disord 13: 566-569, 1998.
5. Earley CJ, Yaffee JB, Allen RP. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 51: 1599-1602, 1998.
6. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52: 944-950, 1999.
7. Trenkwalder C, Hundemer HP, Lledo A, et al. PEARLS Study Group. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology 62: 1391-1397, 2004.
8. Lin SC, Kaplan J, Burger CD, Fredrickson PA. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc 73: 497-500, 1998.
9. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 52: 938-943, 1999.
10. Silber MH, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep 26: 819-821, 2003.
11. Ondo W. Ropinirole for restless legs syndrome. Movment Disord 14: 138-140, 1999.
12. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Therapy with Ropiunirole; Efficacy and Tolerability in RLS 1 Study Group. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75: 92-97, 2004.
13. Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K. TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 19: 1414-1423, 2004.
14. Stiasny K, Röbbecke J, Schöller P, Oertel WH. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline-an open clinical trial. Sleep 23: 349-354, 2000.
15. Porter MC, Appiah-Kubf LS, Chaudhuri KR. Treatment of Parkinson's disease and restless legs syndrome with cabergoline, a long-acting dopamine agonist. Int J Clin Pract 56: 468-474, 2002.
16. Stiasny-Kolster K, Benes H, Peglau I, et al. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology 63: 2272-2279, 2004.
17. Phillips B, Young T, Finn L, Asher K, Hening WN, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 160: 2137-2141, 2000.
18. Comella CL. Restless legs syndrome. Treatment with dopaminergic agents. Neurology 58 (suppl 1): S87-S92, 2002.
19. Tan EK, Seah A, See SJ, Lim E, Wong MC, Koh KK. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 16: 577-579, 2001.
20. Montplaisir J, Boucher S, Poirier G, Lanigne G, Lapierre O. Lesperance. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 12: 61-65, 1997.
21. Winkelmann J, Wetter TC, Collado-Seidel V, et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 23: 597-602, 2000.
22. Winkelmann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 52: 297-302, 2002.
23. Walters AS, LeBrocq C, Dhar A, et al. International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4: 121-132, 2003.
24. Lesage S, Earley CJ. Restless legs syndrome. Curr Treat Options Neurol 6: 209-219, 2004.
25. Walters AS, Hickey K, Maltzman J, et al. A questionnaire study of 138 patients with restless legs syndrome: the 'night-walkers' survey. Neurology 46: 92-95, 1996.
26. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5: 237-246, 2004.